Lorvotuzumab (Anti-NCAM1 / CD56)
Lorvotuzumab (Anti-NCAM1 / CD56) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine. MW: 145.5 kD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2393 |
Sku # | A2393-1mg*5 |
Pricing | 1mg*5, $1390.00 |